Cesca Therapeutics Inc. (KOOL)

0.31
0.01 1.60
NASDAQ : Health Technology
Prev Close 0.32
Open 0.32
Day Low/High 0.30 / 0.32
52 Wk Low/High 0.21 / 3.34
Volume 145.94K
Avg Volume 124.60K
Exchange NASDAQ
Shares Outstanding 21.65M
Market Cap 7.07M
EPS -0.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Cesca Therapeutics To Present At The BIO CEO & Investor Conference

Cesca Therapeutics To Present At The BIO CEO & Investor Conference

RANCHO CORDOVA, Calif., Feb.

ThermoGenesis Corp® Completes Construction And Qualification Of In-House Clean Room For Assembly Of All X-Series™ Cell Processing Disposables

ThermoGenesis Corp® Completes Construction And Qualification Of In-House Clean Room For Assembly Of All X-Series™ Cell Processing Disposables

Transfer from Third Party to In-house Assembly Allows for Greater Control Over Quality, Scale and Costs

Cesca Therapeutics Announces Third Quarter 2018 Financial Results And Provides Corporate Update

Cesca Therapeutics Announces Third Quarter 2018 Financial Results And Provides Corporate Update

Conference Call to be Held at 4:30 p.m. EST (1:30 p.m. PST)

Cesca Therapeutics Inc. Announces Release Of X-Mini™ Cell Selection Kit For The CAR-T Research Market

Cesca Therapeutics Inc. Announces Release Of X-Mini™ Cell Selection Kit For The CAR-T Research Market

X-Mini is the first in a series of kits that comprise the company's CAR-TXpress™ platform

Cesca Therapeutics Expands CAR-TXpress™ Intellectual Property Portfolio With Filing Of New Patent Covering Cell Activation & Transduction

Cesca Therapeutics Expands CAR-TXpress™ Intellectual Property Portfolio With Filing Of New Patent Covering Cell Activation & Transduction

Invention further streamlines ThermoGenesis' CAR-TXpress workflow, improving efficiency and reducing costs

Cesca Therapeutics Announces Issuance Of Second Cellular Processing Patent

Cesca Therapeutics Announces Issuance Of Second Cellular Processing Patent

Intellectual Property Position Surrounding the Company's X-BACS Technology is Significantly Strengthened

Cesca Therapeutics Announces Financial Results For The Three Months Ended September 30, 2017 And Provides Corporate Update

Cesca Therapeutics Announces Financial Results For The Three Months Ended September 30, 2017 And Provides Corporate Update

Conference Call to be Held at 4:30 p.m. EST (1:30 p.m. PST)